{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:58:55Z","timestamp":1766512735570,"version":"3.48.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"DOI":"10.7759\/cureus.99944","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:56:51Z","timestamp":1766512611000},"source":"Crossref","is-referenced-by-count":0,"title":["IgG4-Related Disease With Lung and Kidney Involvement: A Case Report"],"prefix":"10.7759","author":[{"given":"Andreia","family":"S\u00e1 Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Castro Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Veiga de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Ricardo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01240-x","article-title":"IgG4-related disease and other fibro-inflammatory conditions","volume":"21","author":"Peyronel F","year":"2025","unstructured":"Peyronel F, Della-Torre E, Maritati F, Urban ML, Bajema I, Schleinitz N, Vaglio A. IgG4-related disease and other fibro-inflammatory conditions. Nat Rev Rheumatol. 2025, 21:275-90. 10.1038\/s41584-025-01240-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf008","article-title":"IgG4-related disease: lessons from the first 20 years","volume":"64","author":"Stone JH","year":"2025","unstructured":"Stone JH. IgG4-related disease: lessons from the first 20 years. Rheumatology (Oxford). 2025, 64:i24-7. 10.1093\/rheumatology\/keaf008","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta M","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020, 369:m1067. 10.1136\/bmj.m1067","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace ZS","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al.. The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020, 72:7-19. 10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-related disease","volume":"392","author":"Stone JH","year":"2025","unstructured":"Stone JH, Khosroshahi A, Zhang W, et al.. Inebilizumab for treatment of IgG4-related disease. N Engl J Med. 2025, 392:1168-77. 10.1056\/NEJMoa2409712","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00022-5","article-title":"Proliferative features of IgG4-related disease","volume":"6","author":"Katz G","year":"2024","unstructured":"Katz G, Hernandez-Barco Y, Palumbo D, Guy TV, Dong L, Perugino CA. Proliferative features of IgG4-related disease. Lancet Rheumatol. 2024, 6:e481-92. 10.1016\/S2665-9913(24)00022-5","journal-title":"Lancet Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00299-0","article-title":"Fibrotic phenotype of IgG4-related disease","volume":"6","author":"Lanzillotta M","year":"2024","unstructured":"Lanzillotta M, Culver E, Sharma A, Zen Y, Zhang W, Stone JH, Della-Torre E. Fibrotic phenotype of IgG4-related disease. Lancet Rheumatol. 2024, 6:e469-80. 10.1016\/S2665-9913(23)00299-0","journal-title":"Lancet Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.06.010","article-title":"An update on IgG4-related lung disease","volume":"66","author":"Morales AT","year":"2019","unstructured":"Morales AT, Cignarella AG, Jabeen IS, Barkin JS, Mirsaeidi M. An update on IgG4-related lung disease. Eur J Intern Med. 2019, 66:18-24. 10.1016\/j.ejim.2019.06.010","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101452","article-title":"IgG4 related lung disease- a rare and novel mimic of malignancy and infections-a case series of three patients with a brief review of updated literature","volume":"33","author":"Nasrullah A","year":"2021","unstructured":"Nasrullah A, Javed A, Alvi Z, Raja A, Ashraf O, Malik K, Balaan M. IgG4 related lung disease- a rare and novel mimic of malignancy and infections-a case series of three patients with a brief review of updated literature. Respir Med Case Rep. 2021, 33:101452. 10.1016\/j.rmcr.2021.101452","journal-title":"Respir Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14422","article-title":"Thoracic manifestations of IgG4-related disease","volume":"28","author":"Muller R","year":"2023","unstructured":"Muller R, Ebbo M, Habert P, et al.. Thoracic manifestations of IgG4-related disease. Respirology. 2023, 28:120-31. 10.1111\/resp.14422","journal-title":"Respirology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/4421589","article-title":"Renal manifestations of IgG4-related disease: a concise review","volume":"2024","author":"Towheed ST","year":"2024","unstructured":"Towheed ST, Zanjir W, Ren KY, Garland J, Clements-Baker M. Renal manifestations of IgG4-related disease: a concise review. Int J Nephrol. 2024, 2024:4421589. 10.1155\/2024\/4421589","journal-title":"Int J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B lymphocytes directly contribute to tissue fibrosis in patients with IgG(4)-related disease","volume":"145","author":"Della-Torre E","year":"2020","unstructured":"Della-Torre E, Rigamonti E, Perugino C, et al.. B lymphocytes directly contribute to tissue fibrosis in patients with IgG(4)-related disease. J Allergy Clin Immunol. 2020, 145:968-81.e14. 10.1016\/j.jaci.2019.07.004","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.06.009","article-title":"Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: a systematic review and meta-analysis","volume":"21","author":"Lanzillotta M","year":"2021","unstructured":"Lanzillotta M, Della-Torre E, Wallace ZS, et al.. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: a systematic review and meta-analysis. Pancreatology. 2021, 21:1395-401. 10.1016\/j.pan.2021.06.009","journal-title":"Pancreatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00157-1","article-title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial","volume":"5","author":"Perugino CA","year":"2023","unstructured":"Perugino CA, Wallace ZS, Zack DJ, et al.. Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial. Lancet Rheumatol. 2023, 5:e442-50. 10.1016\/S2665-9913(23)00157-1","journal-title":"Lancet Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444863-igg4-related-disease-with-lung-and-kidney-involvement-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:56:52Z","timestamp":1766512612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444863-igg4-related-disease-with-lung-and-kidney-involvement-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.99944","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}